Tomasz M. Beer, Dianne Lemmon, Bruce A. Lowe and W. David Henner High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma Cancer 97
Version of Record online: 20 FEB 2003 | DOI: 10.1002/cncr.11179
Weekly administration of high-dose calcitriol has been found to be safe, even over prolonged periods of time. Of 22 patients, three (14%) had prostate specific antigen (PSA) reductions that ranged from 10–47%. An additional three patients (14%) had statistically significant increases in PSA doubling time with this regimen.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field